Hertility is a data-driven women’s health platform combining advanced diagnostics, proprietary AI-powered clinical decision support, and end-to-end care to enable earlier, faster, and more accurate detection and treatment across the female lifespan. Hertility has built the world’s largest multimodal dataset in women’s health, powering a clinical-grade AI diagnostic that screens for 25 health states (including 18 conditions) with 98–99% precision, validated across 29 research studies. This is paired with a Software as a Medical Device (SaMD) and integrated patient management system that automates clinical workflows, including AI-assisted ultrasound interpretation and automated reporting, enabling clinicians to scale care delivery efficiently. In the next 6 months, alongside the NVIDIA inception programme, they will scale globally and initiate the first foundational AI model for women’s health. We’re calling this the Reproductive Revolution!